From indomethacin to a selective COX-2 inhibitor. Development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors
- Adv Exp Med Biol. 1997:407:73-8.
Affiliations
- 1. Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Québec, Canada.
PMID: 9321934
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: COXResearch Areas: Inflammation/Immunology